{"art_url":"https://d1liwsgvdtvkdb.cloudfront.net/art/q_6a90a021a1ee0ba1b3/qm-ascii-fit-v1/6b1dc3bd9984ceab27774aa32e85ffe4bf0f10dd5f7e2cfda968a2db5b74d3fd/1200.jpg","art_url_600":"https://d1liwsgvdtvkdb.cloudfront.net/art/q_6a90a021a1ee0ba1b3/qm-ascii-fit-v1/6b1dc3bd9984ceab27774aa32e85ffe4bf0f10dd5f7e2cfda968a2db5b74d3fd/600.jpg","id":"q_6a90a021a1ee0ba1b3","text":"Do GLP-1 receptor agonists reduce Alzheimer's disease risk?","display_title":null,"slug":"do-glp-1-receptor-agonists-reduce-alzheimer-s-disease-risk","status":"answered","entities":["GLP1","ALZHEIMERS","HEALTH"],"ref_url":null,"forecasters":null,"created":"2026-08-27T20:37:53.162771Z","budget_cents":100,"tier":"standard","raised_cents":100,"funders":1,"artifact":{"id":"a_6a90a12be3dfb96a5d","question_id":"q_6a90a021a1ee0ba1b3","latest_rev":1,"machine_price_cents":50,"freshness_hours":72,"external_url":null,"teaser":{"summary":"No. GLP-1 receptor agonists have not been shown to reduce clinical Alzheimer’s risk; observational associations are likely confounded, and Phase 3 trials failed to slow disease progression.","verdict":"Currently, there is no clinical evidence that GLP-1 receptor agonists (GLP-1 RAs) reduce the risk of developing clinical Alzheimer's disease. While several observational studies have reported associations between GLP-1 RA use in patients with type 2 diabetes and a lower incidence...","citations":4},"downloads":0,"unique_buyers":0,"age_hours":2022.2}}
